| Mar 24, 2022 |
Mar 28, 2022 |
Marker Therapeutics, Inc.
|
COO |
Sell |
83.8
|
+107,358
|
4.19%
|
✗
|
$16.2K |
| Mar 16, 2021 |
Mar 18, 2021 |
Marker Therapeutics, Inc.
|
Chief Development Officer |
Buy |
97.5
|
+571,428
|
28.67%
|
✗
|
$1000K |
| Mar 1, 2021 |
Mar 3, 2021 |
Kalaris Therapeutics, Inc.
|
Director |
Sell |
36.3
|
-63,836
|
-2.66%
|
✓
|
$2.5M |
| Feb 19, 2021 |
Feb 23, 2021 |
Kalaris Therapeutics, Inc.
|
Director |
Sell |
40.0
|
-36,404
|
-1.49%
|
✓
|
$1.5M |
| Feb 18, 2021 |
Feb 19, 2021 |
Kalaris Therapeutics, Inc.
|
Director |
Sell |
46.3
|
-8,942
|
-0.37%
|
✓
|
$364.4K |
| Feb 16, 2021 |
Feb 18, 2021 |
Kalaris Therapeutics, Inc.
|
Director |
Sell |
45.0
|
-17,860
|
-0.72%
|
✓
|
$736.3K |